Trabalhos completos publicados em periódicos

Trabalhos completos publicados em periódicos

Seleção dos mais relevantes desde 2001

De Marco R, Faria TC, Mine KL, Cristelli M, Medina-Pestana JO, Tedesco-Silva H, Gerbase-DeLima M. HLA-A homozygosis is associated with susceptibility to COVID-19. HLA. 2021;98:122-131. doi: 10.1111/tan.14349.
Iacontini EGR, Rampim GF, Terapin CF, de Lima MG, de Freitas Dutra V. Identification of the novel HLA-a*68:250 allele in a volunteer bone marrow donor from Sao Paulo, Brazil. HLA. 2021; 97:541-543. doi: 10.1111/tan.14253.
Gerbase-Delima M,de Marco R, Monteiro F,Tedesco-Silva H, Medina-Pestana JO,Mine KL.Impact of combinations of donorand recipient ages and other factors on kidney graft outcomes. Front lmmunol. 2020;22;11:954.doi: 0.3389/ fimmu.2020.00954.
GrenziPC, Campos EF,Tedesco-Silva H Jr,Felipe CR, Soares MF, Medina-Pestana J,Hansen HP, Gerbase-Delima M. Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients. Hum lmmunol. 2018;79:550-557. doi: 10.1016/j.humimm.2018.04.002.
Mine KL, Tedesco-Silva H, Mourao TB,Campos EF,Salzedas LA, Aguiar B,Felipe CR, Medina-Pestana JO, Gerbase-Delima M. Heightened expression of HLA-DQBl and HLA-DQB2 in pre-implantation biopsies predicts poorlate kidney graft function. Hum lmmunol. 2018;79:594-60 1.doi: 10.1016/j.humimm.2018.05.002.
Rampim GF,Araujo AS, Mourao TB, Furuyama TN,Gerbase-Delima M. HLA-B'15:04:04, a novelHLA allele identified duringproficiency testingin Brazil. HLA. 2016;88:200-1. doi:10.1111/tan.12866.
Mourao TB,Mine KL, Campos EF,Medina-Pestana JO, Tedesco-Silva H,Gerbase-DeLima M. Predicting delayed kidney graft function with gene expression in preimplantation biopsies and first-day posttransplant blood.Hum lmmunol. 2016;77:353-7.doi: 10.1016/j.humimm.2016.02.002.
GrenziPC, Campos EF,Silva HT Jr,Felipe CR, Franco MF, Soares MF,Medina-Pestana JO, Gerbase- Delima M. Post-transplant soluble CD30levels are associated with early subclinicalrejection in kidney transplantation. Transpl lmmunol.2015;32:61-5. doi:10.1016/j.trim.2015.02.004.
Echeverria VF,Rampim GF,Gerbase-Delima M. The HLA-A 02:481allele was identified in unrelated Brazilians sharing HLA-B. 15:17,C-07:01P,DRBl*13:02 and DQB •o6:04.Tissue Antigens. 20 14; 84:577-8. doi: 10.1111/tan.12468.
Goncalves-Primo A, Mourao TB, Andrade-Oliveira V, Campos EF,Medina-Pestana JO,Tedesco-Silva H, Gerbase-Delima M. Investigation of apoptosis-related gene expression levels in preimplantation biopsies as predictors of delayed kidney graft function. Transplantation. 2014;97:1260-5. doi: 10.1097/01.TP.0000442579.12285.e8
GrenziPC, Campos EF,Tedesco-S ilva H, Felipe CR, Franco MF,Soares MF,Medina-Pestana JO, Gerbase-Delima M.Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.Transpl lmmunol. 2013;29:34-8. doi:10.1016/j.trim.2013.07.003.
GrenziPC, de Marco R,Silva RZ, Campos EF,Gerbase-Delima M.Antibodies against denatured HLA class II molecules detected in Luminex-single antigen assay. Hurn lmmunol. 2013;74:1300-3. doi: 10.1016/j.humimm.20 13.06.035.
Susa! C, Roelen DL, Fischer G, Campos EF,Gerbase-Delima M, Honger G, Schaub S, Lachmann N, Martorell J, Claas F.Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients.Tissue Antigens. 2013;82:83 92. doi: 10.1111/tan.12137.
Mine KL,Shulzhenko N,Yambartsev A, Rochman M, Sanson GF,Lando M,Varma S, Skinner J, Volfovsky N, Deng T,Brenna SM, Carvalho CR,Ribalta JC, Bustin M, Matzinger P,Silva ID,Lyng H,Gerbase-Delima M, Morgun A.Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer. Nat Commun. 2013; 4:1806. doi: 10.1038/ncomms2693.
Andrade-Oliveira V, Campos EF,Goncalves-Primo A, GrenziPC, Medina-Pestana JO, Tedesco-Silva H, Gerbase-Delima M.TLR4 mRNAlevels as tools to estimate risk for early posttransplantat ion kidney graft dysfunction. Transplantation.2012;94:589-95.DOI:10.1097/TP.Ob013e3 1825db680.
Cangussu LO, Teixeira R,Campos EF,Rampim GF,Mingoti SA, Martins-Filho OA, Gerbase-Delima M. HLA class IIalleles and chronic hepatitis C virus infection. Scand J lmmunol. 2011;74:282-7.doi: 10.ll /j.1365-3083.2011.02568.x.
Veiga TR, Rampim GF,Gerbase-Delima M. Identification of a novelHLA-B*52 allele in a Brazilian individual: B'52:21. Tissue Antigens. 2011;77:342 3.doi:10. ll /j .l:J.99 0039.2011.01640.x.
Veiga TR, Rampim GF, de Lima MG. Identification of two novel HLA-Balleles inthe Brazilian population: B.4509 and B.5212. Tissue Antigens. 2010;76:153-4. doi: O.ll l/j.1399-0039.2010.01487.x.
Thakkinstian A, Dmitrienko S, Gerbase-Delima M,McDaniel DO,Inigo P,Chow KM, McEvoy M,lngsathit A, Trevillian P,Barber WH,Attia J. Association between cytokine gene polymorphisms and outcomes in renal transplantation:a meta-analysis of individualpatient data. Nephrol DialTransplant. 2008;23:3017-23.doi: 10.1093/ndt/gfnl85.
Campos EF,Tedesco-Silva H,Machado PG, Franco M, Medina-Pestana JO, Gerbase-Delima M. Post-transplant anti-HLA class IIantibodies as risk factor for late kidney allograft failure.Am J Transplant. 2006;6:2316-20. doi: 10.ll l/j.1600-6143.2006.01503.x.
Gerbase-Delima M,Campos EF,Tedesco-Silva H, Machado PG,Franco M,Medina-Pestana JO. Anti-HLA class IIantibodies and chronic allograft nephropathy. ClinTranspl. 2006:201-5. PMID: 18365378
Morgun A, Shulzhenko N,Perez-Diez A, Diniz RV,Sanson GF,Almeida DR, Matzinger P,Gerbase-DeLima M. Molecular profiling improves diagnoses of rejection and infection in transplanted organs.Circ Res. 2006;98:e74-83. doi:10.1161/0l.res.0000228714.15691.8a.
Perez EC, Shulzhenko N, Morgun A, Diniz RV,Almeida DR, Musatti CC, Gerbase-DeLima M. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardialbiopsies of human cardiac allografts. Hum lmmunol. 2006;67:22-6.doi: 10.1016/j.humimm.2006.02.037.
Kayser C, Alvarenga MC, Neves AS, Gerbase-De Lima M,Andrade LE. Severe ankylosing spondylitis and diffuse systemic sclerosis:case report of a genetic trap. Scand J Rheumatol. 2005;34:145-7. doi: 10.1080/03009740510026346.
Morgun A, Shulzhenko N, Socorro-Silva A, Diniz RV,Almeida DR, Gerbase-Delima M.T cell receptor excision circles (TRECs) in relation to acute cardiac allograft rejection.J Clin lmmunol. 2004;24:612-6. doi: 10.1007/sl0875-004-6246- l.
Witt CS, Goodridge J, Gerbase-Delima MG, Daher S, Christia nsen FT.MaternalKIR repertoireis not associated with recurrent spontaneous abortion. Hum Reprod.2004;19:2653-7.doi: 10.1093/humrep/deh483.
Morgun A, Shulzhenko N, Unterkircher CS, Diniz RV,Pereira AB,Silva MS, Nishida SK,Almeida DR, Carvalho AC, Franco M, Souza MM, Gerbase-Delima M. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome. J Heart Lung Transplant. 2004;23:204-9. doi: 10.1016/S 1053-2498( 03)00114-1.
Borducchi OM, Gerbase-Delima M, Morgun A, Shulzhenko N, Pombo-de-Oliveira MS,Kerbauy J,Rodrigues de Oliveira JS.Human leucocyte antigen and human T-celllymphotropic virus type 1associated diseases in Brazil. Br J Haematol. 2003;123:954-5. doi: 10.1046/j.1365-2141.2003.04711.x.
Morgun A, Shulzhenko N, Rampim GF,Medina JO, Machado PG, Diniz RV,Almeida DR, Gerbase-Delima M. lnterleukin-2 gene polymorphism is associated with rena1Ibut not cardiac transplant outcome.Transplant Proc. 2003;35:1344-5. doi:10.1016/s004 1-1345(03)00366-x.
Morgun A, Shulzhenko N, Rampim GF, Chinellato AP,Diniz RV, Almeida DR, Souza MM, Franco M, Gerbase-Delima M. Blood and intragraft CD27 gene expression incardiac transplant recipients.Clin lmmunol. 2003;107:60-4. doi: 10.1016/sl521-6616(02)00047-5.
TorrecilhasAC, Medina JO, Panajotopoulos N, Moura LA, Gerbase-Delima M.Detection and clinical significance of lymphocytotoxic antibodies following renaltransplantation. Transplant Proc. 2002;34:482-3. doi: 10.1016/s0041-1345(02)02603-9.
Shulzhenko N, Morgun A,Chinellato AP,Rampim GF,Diniz RV, Almeida DR, Gerbase-Delima M. CD27 but not CD70 and 4- BB intragraft gene expression isa risk factor for acute cardiac allograft rejection in humans. Transplant Proc. 2002;34:474-5. doi: 10.1016/s0041-1345(02)02600-3.
Morgun A, Shulzhenko N, Silva ID, Rampim GF,Chinellato A P,Borra RC, Gerbase-Delima M. Differentially expressed genes in cardiac transplant biopsies and in mixed lymphocyte culture.Transplant Proc. 2002;34:471-3. doi: 10.1016/s0041-l345(02)02599-x.
Shulzhenko N, Morgun A, Zheng XX, Diniz RV,Almeida DR, Ma N,Strom TB, Gerbase-Delima M. lntragraft activation of genes encoding cytotoxic Tlymphocyte effector molecules precedes the histologicalevidence of rejection in human cardiac transplantation. Transplantation. 2001;72:1705-8. doi: 10.1097/00007890-200111270-00025.
Shulzhenko N, Morgun A, Franco M, Souza MM,Almeida DR,Diniz RV,Carvalho AC, Pacheco-Silva A, Gerbase-Delima M. Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts:correlation with acute rejection. Braz J Med Biol Res. 2001;34:779-84. doi: 10.1590/s0100-879x2001000600013.
Shulzhenko N, Morgun A, Rampim GF,Franco M,Almeida DR, Diniz RV,CarvalhoAC,Gerbase-Delima M. Monitoringof intragraft and peripheralblood TIRC7 expression as a diagnostic tool for acute cardiac rejection in humans. Hum lmmunol. 2001;62:342-7. doi: 10.1016/s0198-8859(01)00211-7.
Morgun A, Shulzhenko N, Diniz RV,Almeida DR, Carvalho AC, Gerbase-De ima M. Cytokine and TIRC7 mRNA expression duringacute rejection in cardiac allograft recipients. Transplant Proc. 2001;33:1610-1.doi: 10.1o16/s0041-134S(00)02613-0.